The core idea

The mitochondrial metabolic theory

Seyfried builds on the 1920s work of Nobel laureate Otto Warburg: cancer is, at its origin, a disease of cellular energy - not of the genome.

The Warburg effect is the observation, first made by Otto Warburg in the 1920s, that cancer cells ferment glucose to lactate even when oxygen is plentiful - a wasteful route to energy that healthy cells normally take only when starved of oxygen.

The mitochondria: the cell’s engine and its brain

Mitochondria are organelles in the cytoplasm of every cell - historically called “the powerhouse of the cell.” They are not simple beans but a dynamic tubular network that takes in oxygen and produces ATP, the chemical energy currency that runs all cellular machinery. Crucially, Seyfried argues they do far more than make energy: they also act like a brain, signalling to the nucleus and neighbouring cells, and regulating when a cell should divide and when it should stop.

“Structure determines function. If the structure is abnormal, the function will be abnormal. This is known to all biologists - except, it seems, oncologists.”

Under the electron microscope, Seyfried says, cancer cells consistently show damaged mitochondria - missing or deformed internal folds (cristae), sometimes hollow “ghost mitochondria.” Because structure dictates function, damaged mitochondria cannot produce energy normally.

The Warburg effect: fermenting even with oxygen

Otto Warburg observed something strange: cancer cells keep fermenting - producing lactic acid - even in 100% oxygen, when they should be using oxygen for efficient respiration. He proposed the mitochondria were irreversibly damaged. Critics countered that some cancer cells still take in oxygen, so Warburg must be wrong. Seyfried’s resolution: those cells take in oxygen, but use it to generate damaging reactive oxygen species (ROS) rather than meaningful ATP - the ROS then drive the DNA mutations everyone else is chasing.

The ancient survival switch

Life first evolved without oxygen, as single cells that fermented and grew without restraint. When bacteria (the ancestors of mitochondria) fused into early cells, they added efficient oxygen-based energy and the regulation that made multicellular cooperation possible. Seyfried’s picture of cancer: when the mitochondrion is chronically damaged, the cell falls back on that pre-oxygen, “selfish” fermentation program - unregulated growth returns.

Fermentation is wildly inefficient. Oxygen-based respiration yields roughly 34-36 ATP per glucose; fermentation yields about 2. To compensate, the cancer cell must import enormous quantities of fuel - which is why tumours are so “greedy” for glucose and glutamine.

The two fuels: glucose and glutamine

Deprived of efficient respiration, the cancer cell runs on two fermentable fuels:

Critically, cancer cells cannot efficiently burn fatty acids or ketones, because that requires healthy mitochondria. This asymmetry is the entire basis of metabolic therapy: shift the body’s fuel toward ketones, and healthy cells thrive while cancer cells are starved.

The oncogenic paradox - solved?

Albert Szent-Györgyi posed a paradox: many different things cause cancer - viruses, carcinogens, chronic inflammation, intermittent hypoxia, rare inherited mutations - yet no one could name the common mechanism linking them. Seyfried’s answer: every one of those agents damages oxidative phosphorylation in the mitochondria, triggering compensatory fermentation and dysregulated growth. One final common pathway.

Why he thinks mutations are downstream

Seyfried cites classic nuclear-transfer experiments: put a tumour nucleus into a healthy cell’s cytoplasm and you often get no dysregulated growth; put a normal nucleus into a tumour cell’s cytoplasm and growth does become dysregulated. If mutations in the nucleus were the cause, the result should be the opposite. He also points to “wild-type” cancers with no driver mutations, and to inherited risk genes (like BRCA1) that are not 100% penetrant - each, he argues, ultimately disturbing mitochondrial energy production.

The mechanism at a glance

  1. 01

    A stressor damages the mitochondria

    Carcinogens, chronic inflammation, intermittent hypoxia (e.g. sleep apnoea), viruses, microplastics, "forever chemicals", radiation and chronic emotional stress all damage the delicate inner membranes of the mitochondria, reducing their ability to make energy with oxygen.

  2. 02

    Oxidative phosphorylation becomes inefficient

    The mitochondrion can no longer produce enough ATP efficiently through oxygen-based respiration. If the damage were acute the cell would simply die; chronic, gradual damage instead forces the cell to compensate.

  3. 03

    The cell falls back on ancient fermentation

    To survive, the cell reverts to evolutionarily ancient, oxygen-independent fermentation pathways - burning glucose and the amino acid glutamine. This produces far less energy per unit of fuel, and dumps out lactic acid and succinic acid as waste.

  4. 04

    Growth becomes dysregulated - this is cancer

    Because the mitochondria normally regulate when a cell divides, losing that control returns the cell to a "selfish", unregulated growth pattern. The nucleus opens the floodgates (via oncogenes) to import ever more glucose and glutamine. DNA mutations, in this view, are downstream effects of the damage - not the root cause.

This is a contested reframing of cancer biology. Mainstream oncology and the U.S. National Cancer Institute describe cancer primarily as a genetic disease. Presented here as the interviewee’s argument.

Sources

  1. Warburg O (1956). On the origin of cancer cells. Science. doi:10.1126/science.123.3191.309
  2. Szent-Györgyi A (1977). The living state and cancer. Proceedings of the National Academy of Sciences. doi:10.1073/pnas.74.7.2844
  3. Seyfried TN, Shelton LM (2010). Cancer as a metabolic disease. Nutrition & Metabolism. doi:10.1186/1743-7075-7-7
  4. Seyfried TN (2015). Cancer as a mitochondrial metabolic disease. Frontiers in Cell and Developmental Biology. doi:10.3389/fcell.2015.00043